Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Employed in in vitro research examining cooperative GHRHR and GHSR-1a co-stimulation in dual-receptor cell line models and cAMP accumulation assays
Similar patterns are expected with retatrutide, though specific discontinuation data has not yet been published
Better glucose regulation can support healthier energy levels and reduced fat storage
Quick Comparison : Key Takeaway : GLP-1 therapies may offer better weight loss and metabolic improvements, but side effects, cost, and access limit adherence
Tirzepatide (dual GLP-1/GIP receptor agonist): In the SURMOUNT-1 trial, participants on the highest tirzepatide dose (15 mg) achieved approximately 22.5% body weight reduction at 72 weeks
US$ 20.34
US$ 29.43
US$ 27.03
US$ 27.75
US$ 26.60
US$ 20.42
US$ 20.02
US$ 26.34
US$ 25.48
